Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes
Vineela Parvathaneni, Rasha S. Elbatanony, Mimansa Goyal, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4783-4783
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Targeting OXPHOS and the electron transport chain in cancer; Molecular and therapeutic implications
John Greene, Ashvina Segaran, Simon Lord
Seminars in Cancer Biology (2022) Vol. 86, pp. 851-859
Open Access | Times Cited: 102
Integrating natural compounds and nanoparticle‐based drug delivery systems: A novel strategy for enhanced efficacy and selectivity in cancer therapy
Asma Manzari‐Tavakoli, Amirhesam Babajani, Maryam Manzari Tavakoli, et al.
Cancer Medicine (2024) Vol. 13, Iss. 5
Open Access | Times Cited: 26
Cubosomes in cancer drug delivery: A review
Ryan Varghese, Sahil Salvi, Purab Sood, et al.
Colloids and Interface Science Communications (2021) Vol. 46, pp. 100561-100561
Open Access | Times Cited: 53
Inhalation delivery of repurposed drugs for lung cancer: Approaches, benefits and challenges
Popat Kumbhar, Arehalli S. Manjappa, Rohit Shah, et al.
Journal of Controlled Release (2021) Vol. 341, pp. 1-15
Closed Access | Times Cited: 52
Inhalable bedaquiline-loaded cubosomes for the treatment of non-small cell lung cancer (NSCLC)
Suyash M. Patil, Shruti S. Sawant, Nitesh K. Kunda
International Journal of Pharmaceutics (2021) Vol. 607, pp. 121046-121046
Closed Access | Times Cited: 50
Nanoplatform-based natural products co-delivery system to surmount cancer multidrug-resistant
Yan Liang, Ze-Yun Liu, Pingyu Wang, et al.
Journal of Controlled Release (2021) Vol. 336, pp. 396-409
Closed Access | Times Cited: 44
Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems
George Doumat, Darine Daher, Morgan Bou Zerdan, et al.
Current Oncology (2023) Vol. 30, Iss. 1, pp. 704-719
Open Access | Times Cited: 19
A quality-by-design strategic approach for the development of bedaquiline-pretomanid nanoparticles as inhalable dry powders for TB treatment
Suyash M. Patil, Alec M. Diorio, Parasharamulu Kommarajula, et al.
International Journal of Pharmaceutics (2024) Vol. 653, pp. 123920-123920
Closed Access | Times Cited: 4
Enhanced oral delivery of hesperidin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for augmenting its hypoglycemic activity: in vitro-in vivo assessment study
Mona Ebrahim Elmoghayer, Noha Mohamed Saleh, Irhan Ibrahim Abu Hashim
Drug Delivery and Translational Research (2023) Vol. 14, Iss. 4, pp. 895-917
Open Access | Times Cited: 11
Parietin Cyclodextrin-Inclusion Complex as an Effective Formulation for Bacterial Photoinactivation
Abdallah M. Ayoub, Bernd Gutberlet, Eduard Preis, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 357-357
Open Access | Times Cited: 20
Solubility Enhancement and Inhalation Delivery of Cyclodextrin-Based Inclusion Complex of Delamanid for Pulmonary Tuberculosis Treatment
Suyash M. Patil, Druva Sarika Barji, Tejashri Chavan, et al.
AAPS PharmSciTech (2023) Vol. 24, Iss. 1
Closed Access | Times Cited: 10
A Synergistic pH-Responsive Serum Albumin-Based Drug Delivery System Loaded with Doxorubicin and Pentacyclic Triterpene Betulinic Acid for Potential Treatment of NSCLC
Zally Torres‐Martínez, Daraishka Pérez, Grace Torres, et al.
BioTech (2023) Vol. 12, Iss. 1, pp. 13-13
Open Access | Times Cited: 9
Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine – Development & characterization in physiologically relevant 3D tissue models
Dnyandev Gadhave, Mural Quadros, Akanksha Ravindra Ugale, et al.
International Journal of Biological Macromolecules (2024) Vol. 267, pp. 131491-131491
Closed Access | Times Cited: 2
Poly vinyl pyrrolidone (PVP) based inhaled delivery carriers for olaparib for non-small cell lung cancer (NSCLC) treatment
Mimansa Goyal, Gauravi Tulsyan, Dipti Kanabar, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104767-104767
Closed Access | Times Cited: 6
Smart Lipid‐Based Nanoparticles in Lung Cancer Treatment: Current Status and Future Directions
Ramin Yousefpour Shahrivar, Zahra Ahmadi Fakhr, Elham Abbasgholinejad, et al.
Advanced Therapeutics (2023) Vol. 6, Iss. 12
Closed Access | Times Cited: 6
Anticancer activity of D-LAK-120A, an antimicrobial peptide, in non-small cell lung cancer (NSCLC)
Suyash M. Patil, Nitesh K. Kunda
Biochimie (2022) Vol. 201, pp. 7-17
Closed Access | Times Cited: 10
Excipients for Novel Inhaled Dosage Forms: An Overview
Carol Yousry, Mimansa Goyal, Vivek Gupta
AAPS PharmSciTech (2024) Vol. 25, Iss. 2
Closed Access | Times Cited: 1
Drug Repurposing in Cancer Therapy
Srijita Sen, H. S. Kushwah, Om Prakash Ranjan
Drug repurposing (2024), pp. 57-92
Closed Access | Times Cited: 1
Targeting ATP Synthase by Bedaquiline as a Therapeutic Strategy to Sensitize Ovarian Cancer to Cisplatin
Hongyan Zhu, Qitian Chen, Lingling Zhao, et al.
Nutrition and Cancer (2023) Vol. 75, Iss. 4, pp. 1271-1280
Closed Access | Times Cited: 4
Recent Updates in Inhalable Drug Delivery System against Various Pulmonary Diseases: Challenges and Future Perspectives
Kabi Raj Chaudhary, Karanvir Singh, Charan Singh
Current Drug Delivery (2023) Vol. 21, Iss. 10, pp. 1320-1345
Closed Access | Times Cited: 4
Exploring the enhanced stability and therapeutic efficacy of Sorafenib-Cyclodextrin inclusion complex
Snehal K. Shukla, Mimansa Goyal, Dipti Kanabar, et al.
Journal of Molecular Liquids (2024) Vol. 401, pp. 124701-124701
Closed Access
Drug Repurposing for Cancer Treatment: A Comprehensive Review
Abdulaziz H. Al Khzem, Mohamed S. Gomaa, Mansour S. Alturki, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12441-12441
Open Access
Anticancer Activity of Anti-Tubercular Compound(s) Designed on Pyrrolyl Benzohydrazine Scaffolds: A Repurposing Study
Turki Al Hagbani, Afrasim Moin, Talib Hussain, et al.
Processes (2023) Vol. 11, Iss. 7, pp. 1889-1889
Open Access | Times Cited: 1
Decreased Penetration Mechanism of Ranitidine Due to Application of Sodium Sulfobutyl Ether-β-Cyclodextrin
Rui Yang, Jing Zhang, Huang Jiaqi, et al.
(2023)
Open Access | Times Cited: 1
Cubosomes: An Emerging and Promising Drug Delivery System for Enhancing Cancer Therapy
Smita Singh, Kapil Sachan, Suryakant Verma, et al.
Current Pharmaceutical Biotechnology (2023) Vol. 25, Iss. 6, pp. 757-771
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top